GlassScriptPhysician profile
Albert M Marland
NPI 1336184589
$2,980.43
in general payments reported to CMS, 2019-2025
36 companies · $793 in 2025
The $793 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $182 · 2021: $89.26 · 2022: $116 · 2023: $636 · 2024: $803 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,231.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $460.00 | 2020-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $444.82 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $236.65 | 2023-2025 | |
| Amgen INC. | $207.48 | 2019-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $137.92 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Abbott Laboratories | $136.81 | 2022-2023 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $134.36 | 2019-2025 | Gardasil 9, Capvaxive, M-M-R II |
| Philips North America LLC | $113.48 | 2019-2025 | Vest Therapy Und, (8874) Incourage |
| Bayer Healthcare Pharmaceuticals INC. | $105.28 | 2024-2025 | |
| Janssen Pharmaceuticals, INC | $92.13 | 2019-2020 | |
| Electromed, INC. | $90.09 | 2019-2024 | Smartvest |
| Mylan Specialty L.P. | $79.44 | 2019-2020 | |
| Novo Nordisk INC | $76.33 | 2023-2024 | Wegovy, Ozempic, Rybelsus |
| Viiv Healthcare Company | $51.56 | 2024 | Apretude |
| Esperion Therapeutics, INC. | $48.11 | 2025 | Nexletol |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $47.73 | 2019-2024 | Trintellix |
| Insmed, INC. | $44.53 | 2023-2025 | Arikayce |
| Amarin Pharma, INC. | $42.40 | 2019 | |
| Edwards Lifesciences Corporation | $41.05 | 2024 | Sapien 3 Ultra Resilia |
| Exact Sciences Corporation | $37.31 | 2025 | Cologuard Collection Kit |
| Mallinckrodt Hospital Products INC. | $34.54 | 2023 | Acthar |
| Bausch Health US, LLC | $33.30 | 2023 | Wellbutrin, Aplenzin |
| Boston Scientific Corporation | $27.96 | 2024 | Watchman Flx |
| Sanofi Pasteur INC. | $26.79 | 2023 | |
| Baxter Healthcare | $26.53 | 2023 | Hillrom - Life 2000 Ventilation System |
| Nabriva Therapeutics, Plc | $22.87 | 2020 | |
| Xeris Pharmaceuticals, INC. | $21.27 | 2025 | Gvoke Hypopen |
| Eisai INC. | $21.21 | 2024 | |
| Cmp Pharma, INC. | $20.63 | 2023 | Atorvaliq, Liqrev, Tadliq |
| Sumitomo Pharma America, INC. | $20.45 | 2025 | Gemtesa |
| Si-Bone, INC. | $20.34 | 2023 | |
| Therapeuticsmd, INC. | $19.29 | 2019 | |
| Allergan, INC. | $17.93 | 2020 | |
| Seqirus USA INC | $14.15 | 2024 | Fluad, Flucelvax |
| Rgh Enterprises LLC | $13.59 | 2024 | |
| Abbvie INC. | $12.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Marland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.